Mammography service screening and breast cancer mortality in New Zealand: A National Cohort Study 1999-2011

British Journal of Cancer

Volumn 116, Issue 6, 2017, Pages 828-839

  Morrell, Stephen ^a   Taylor, Richard ^a   Roder, David ^b   Robson, Bridget ^c   Gregory, Marli ^d   Craig, Kirsty ^d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d MINISTRY OF HEALTH   (New Zealand)

Author keywords

breast cancer; cohort study; mammography; mortality; New Zealand; service screening

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SCREENING; CANCER SIZE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; ETHNICITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MAORI (PEOPLE); MIDDLE AGED; MULTIPLE CANCER; NEW ZEALAND; PACIFIC ISLANDER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; RISK REDUCTION; SELECTION BIAS; TUMOR DIFFERENTIATION; BREAST NEOPLASMS; CANCER STAGING; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; EPIDEMIOLOGY; HEALTH SURVEY; MORTALITY; PROCEDURES; PROGNOSIS; SURVIVAL RATE; TIME FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM STAGING; NEW ZEALAND; POPULATION SURVEILLANCE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 85011878879     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2017.6     Document Type: Article

References (67)

1. Alexander FE, Anderson TJ, Brown HK, Forrest AP, Hepburn W, Kirkpatrick AE, McDonald C, Muir BB, Prescott RJ, Shepherd SM (1994) The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up. Br J Cancer 70(3): 542-548.
2. Allgood PC, Warwick J, Warren RML, Day NE, Duffy SW (2008) A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality. Br J Cancer 98(1): 206-209.
3. Anttila A, Koskela J, Hakama M (2002) Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland. J Med Screen 9(4): 153-158.
4. Ascunce EN, Moreno-Iribas C, Barcos Urtiaga A, Ardanaz E, Ederra Sanz M, Castilla J, EgOs N (2007) Changes in breast cancer mortality in Navarre (Spain) after introduction of a screening programme. J Med Screen 14(1): 14-20.
5. Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ (2000) Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990?8: comparison of observed with predicted mortality. BMJ 321(7262): 665-669.
6. Broeders M, Moss S, Nyström L, Njor S, Jonsson H, Paap E, Massat N, Duffy S, Lynge E, Paci E, E.U.R.O.S.C.R.E.E.N Working Group (2012) The impact of mammographic screening on breast cancer mortality in europe: a review of observational studies. J Med Screen 19(Suppl 1): 14-25.
7. Broeders MJ, Peer PG, Straatman H, Beex LV, Hendriks JH, Holland R, Verbeek AL (2001) Diverging breast cancer mortality rates in relation to screening? A comparison of Nijmegen to Arnhem and the Netherlands, 1969-1997. Int J Cancer 92(2): 303-308.
8. Burton RC, Bell RJ, Thiagarajah G, Stevenson C (2012) Adjuvant therapy, not mammographic screening, accounts for most of the observed breast cancer specific mortality reductions in australian women since the national screening program began in 1991. Breast Cancer Res Treat 131(3): 949-955.
9. Dijck JAV, Verbeek AL, Beex LV, Hendriks JH, Holland R, Mravunac M, Straatman H, Werre JM (1997) Breast-cancer mortality in a non-randomized trial on mammographic screening in women over age 65. Int J Cancer 70(2): 164-168.
10. Duffy S, Cuzick J, TAbar L, Vitak B, Hsiu-Hsi Chen T, Yen M-F, Smith R (2002a) Correcting for noncompliance bias in case?control studies to evaluate cancer screening programmes. Appl Stat 51: 235-243.
11. Duffy SW, TabAr L, Chen H-H, Holmqvist M, Yen M-F, Abdsalah S, Epstein B, Frodis E, Ljungberg E, Hedborg-Melander C, Sundbom A, Tholin M, Wiege M, Akerlund A, Wu H-M, Tung T-S, Chiu Y-H, Chiu C-P, Huang C-C, Smith RA, RosOñ M, Stenbeck M, Holmberg L (2002b) The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer 95(3): 458-469.
12. Duffy SW, Tabar L, Fagerberg G, Gad A, Gröntoft O, South MC, Day NE (1991) Breast screening, prognostic factors and survival? results from the Swedish two county study. Br J Cancer 64(6): 1133-1138.
13. Duffy SW, TabAr L, Vitak B, Yen MF, Warwick J, Smith RA, Chen HH (2003) The Swedish Two-County Trial of mammographic screening: cluster randomisation and end point evaluation. Ann Oncol 14(8): 1196-1198.
14. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet (London, England) 365: 1687-1717.
15. Freedman DA, Petitti DB, Robins JM (2004) On the efficacy of screening for breast cancer. Int J Epidemiol 33(1): 43-55.
16. Frisell J, Lidbrink E, Hellström L, Rutqvist LE (1997) Followup after 11 years?update of mortality results in the Stockholm mammographic screening trial. Breast Cancer Res Treat 45(3): 263-270.
17. Gabe R, Duffy SW (2005) Evaluation of service screening mammography in practice: the impact on breast cancer mortality. Ann Oncol 16(Suppl 2): ii153-ii162.
18. Gøtzsche P, Jørgensen K (2013) Screening for breast cancer with mammography. Cochrane Database Syst Rev 6: CD001877.
19. Gøtzsche PC, Nielsen M (2006) Screening for breast cancer with mammography. Cochrane Database Syst Rev 4: CD001877.
20. Gøtzsche PC, Nielsen M (2009) Screening for breast cancer with mammography. Cochrane Database Syst Rev 4, CD001877.
21. Gøtzsche PC, Nielsen M (2011) Screening for breast cancer with mammography. Cochrane Database Syst Rev 1: CD001877.
22. Gøtzsche PC, Olsen O (2000) Is screening for breast cancer with mammography justifiable? Lancet 355(9198): 129-134.
23. Hakama M, Pukkala E, Heikkil M, Kallio M (1997) Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. BMJ 314(7084): 864-867.
24. Hofvind S, Ursin G, Tretli S, SebuødegIrd S, Møller B (2013) Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program. Cancer 119(17): 3106-3112.
25. International Agency for Research on Cancer (2002) IARC Handbooks of Cancer Prevention: Breast Cancer Screening. IARC: Lyon, France.
26. International Agency for Research on Cancer (2016) IARC Handbooks of Cancer Prevention, Volume 15, Breast Cancer Screening. IARC, Lyon, France.
27. Irvin VL, Kaplan RM (2014) Screening mammography and breast cancer mortality: meta-analysis of quasi-experimental studies. PLoS One 9(6): e98105.
28. Jonsson H, BordAs P, Wallin H, Nyström L, Lenner P (2007) Service screening with mammography in Northern Sweden: effects on breast cancer mortality-an update. J Med Screen 14(2): 87-93.
29. Jonsson H, Nyström L, Törnberg S, Lenner P (2001) Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer. J Med Screen 8(3): 152-160.
30. Jonsson H, Törnberg S, Nyström L, Lenner P (2000) Service screening with mammography in Sweden-evaluation of effects of screening on breast cancer mortality in age group 40-49 years. Acta Oncol 39(5): 617-623.
31. Jonsson H, Törnberg S, Nyström L, Lenner P (2003) Service screening with mammography of women aged 70-74 years in Sweden. effects on breast cancer mortality. Cancer Detect Prev 27(5): 360-369.
32. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL (1995) Efficacy of screening mammography. A meta-analysis. JAMA 273(2): 149-154.
33. Lawrence G, Wallis M, Allgood P, Nagtegaal ID, Warwick J, Cafferty FH, Houssami N, Kearins O, Tappenden N, O'Sullivan E, Duffy SW (2009) Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias. Breast Cancer Res Treat 116(1): 179-185.
34. Lawrenson R, Seneviratne S, Scott N, Peni T, Brown C, Campbell I (2016) Breast cancer inequities between Mori and non-Mori women in Aotearoa/New Zealand. Eur J Cancer Care 25: 225-230.
35. Lynge E, Braaten T, Njor SH, Olsen AH, Kumle M, Waaseth M, Lund E (2011) Mammography activity in Norway 1983 to 2008. Acta Oncol 50(7): 1062-1067.
36. Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M (2013) The benefits and harms of breast cancer screening: an independent review. Br J Cancer 108(11): 2205-2240.
37. Miller AB, Baines CJ, To T, Wall C (1992) Canadian national breast screening study: 2. breast cancer detection and death rates among women aged 50 to 59 years. CMAJ 147(10): 1477-1488.
38. Morrell S, Taylor R, Roder D, Dobson A (2012) Mammography screening and breast cancer mortality in Australia: an aggregate cohort study. J Med Screen 19(1): 26-34.
39. Morrell S, Taylor R, Roder D, Robson B (2015) Cohort and Case Control Analyses of Breast Cancer Mortality: BreastScreen Aotearoa 1999-2011. New Zealand Ministry of Health: Wellington, New Zealand. Available at: https://www.nsu.govt.nz/system/files/resources/bsnzmortcohcceval-final7-8-dec.pdf.
40. Nelson HD, Fu R, Cantor A, Pappas M, Daeges M, Humphrey L (2016) Effectiveness of breast cancer screening: Systematic review and meta-analysis to update the 2009 U.S. preventive services task force recommendation. Ann Intern Med 164: 244-255.
41. Nickson C, Mason KE, English DR, Kavanagh AM (2012) Mammographic screening and breast cancer mortality: a case?control study and meta-analysis. Cancer Epidemiol Biomarkers Prev 21(9): 1479-1488.
42. Nystrom L, Larsson LG, Wall S, Rutqvist LE, Andersson I, Bjurstam N, Fagerberg G, Frisell J, Tabar L (1996) An overview of the Swedish randomised mammography trials: total mortality pattern and the representivity of the study cohorts. J Med Screen 3(2): 85-87.
43. Olsen AH, Lynge E, Njor SH, Kumle M, Waaseth M, Braaten T, Lund E (2013) Breast cancer mortality in Norway after the introduction of mammography screening. Int J Cancer 132(1): 208-214.
44. Olsen AH, Njor SH, Vejborg I, Schwartz W, Dalgaard P, Jensen M-B, Tange UB, Blichert-Toft M, Rank F, Mouridsen H, Lynge E (2005) Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ 330(7485): 220.
45. Otto SJ, Fracheboud J, Looman CWN, Broeders MJM, Boer R, Hendriks JHCL, Verbeek ALM, de Koning HJ, National Evaluation Team for Breast Cancer Screening (2003) Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 361(9367): 1411-1417.
46. Otto SJ, Fracheboud J, Verbeek ALM, Boer R, Reijerink-Verheij JCIY, Otten JDM, Broeders MJM, de Koning HJ. National Evaluation Team for Breast Cancer Screening (2012) Mammography screening and risk of breast cancer death: a population-based case?control study. Cancer Epidemiol Biomarkers Prev 21(1): 66-73.
47. Paap E, Verbeek ALM, Botterweck AAM, van Doorne-Nagtegaal HJ, Imhof-Tas M, de Koning HJ, Otto SJ, de Munck L, van der Steen A, Holland R, den Heeten GJ, Broeders MJM (2014) Breast cancer screening halves the risk of breast cancer death: a case-referent study. Breast 23(4): 439-444.
48. Paci E, Duffy SW, Giorgi D, Zappa M, Crocetti E, Vezzosi V, Bianchi S, del Turco MR (2002a) Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme 1990?96. Br J Cancer 87(1): 65-69.
49. Paci E, Giorgi D, Bianchi S, Vezzosi V, Zappa M, Crocetti E, Rosselli del Turco M (2002b) Assessment of the early impact of the population-based breast cancer screening programme in Florence (Italy) using mortality and surrogate measures. Eur J Cancer 38(4): 568-573.
50. Page A, Morrell S, Taylor R (2014) Screening and assessment report of women attending BreastScreen Aotearoa: Women screened July 2010-June 2012. BreastScreen Aotearoa, Wellington. Independent Monitoring Group Report.
51. Parvinen I, Helenius H, Pylkknen L, Anttila A, Immonen-Rih P, Kauhava L, Rsnen O, Klemi PJ (2006) Service screening mammography reduces breast cancer mortality among elderly women in Turku. J Med Screen 13(1): 34-40.
52. Peer PG, Werre JM, Mravunac M, Hendriks JH, Holland R, Verbeek AL (1995) Effect on breast cancer mortality of biennial mammographic screening of women under age 50. Int J Cancer 60(6): 808-811.
53. Puliti D, Miccinesi G, Collina N, De Lisi V, Federico M, Ferretti S, Finarelli AC, Foca F, Mangone L, Naldoni C, Petrella M, Ponti A, Segnan N, Sigona A, Zarcone M, Zorzi M, Zappa M, Paci E, I.M.P.A.C.T Working Group (2008) Effectiveness of service screening: a case?control study to assess breast cancer mortality reduction. Br J Cancer 99(3): 423-427.
54. Quinn M, Allen E (1995) Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. United Kingdom Association of Cancer Registries. BMJ 311(7017): 1391-1395.
55. Roder D, Houssami N, Farshid G, Gill G, Luke C, Downey P, Beckmann K, Iosifidis P, Grieve L, Williamson L (2008) Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia. Breast Cancer Res Treat 108(3): 409-416.
56. Seneviratne S, Campbell I, Scott N, Coles C, Lawrenson R (2015) Treatment delay for M?ori women with breast cancer in New Zealand. Ethn Health 20: 178-193.
57. Shapiro S (1997) Periodic screening for breast cancer: the HIP Randomized Controlled Trial. Health Insurance Plan. J Natl Cancer Inst Monogr 22(22): 27-30.
58. Swedish Organised Service Screening Evaluation Group (2006) Reduction in breast cancer mortality from organized service screening with mammography: 1. further confirmation with extended data. Cancer Epidemiol Biomarkers Prev 15(1): 45-51.
59. Tabár L, Fagerberg G, Duffy SW, Day NE, Gad A, Gröntoft O (1992) Update of the swedish two-county program of mammographic screening for breast cancer. Radiol Clin N Am 30(1): 187-210.
60. Tabár L, Vitak B, Chen HH, Yen MF, Duffy SW, Smith RA (2001) Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 91(9): 1724-1731.
61. Tabár L, Yen M-F, Vitak B, Chen HHT, Smith RA, Duffy SW (2003) Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 361(9367): 1405-1410.
62. Taylor R, Morrell S, Estoesta J, Brassil A (2004) Mammography screening and breast cancer mortality in New South Wales, Australia. Cancer Causes Control 15(6): 543-550.
63. Taylor R, Morrell S, Roder D (2009) Screening Monograph No. 4/2009? Mortality (Ecological) Study. Commonwealth Department of Health and Aging (Australia). Available at: http://s3.amazonaws.com/zanran-storage/www.cancerscreening.gov.au/ContentPages/999890649.pdflast (accessed 26 August 2016).
64. Threlfall AG, Collins S, Woodman CBJ (2003) Impact of NHS breast screening on advanced disease and mortality from breast cancer in the North West of England. Br J Cancer 89(1): 77-80.
65. UK Trial of Early Detection of Breast Cancer Group (1999) 16-year mortality from breast cancer in the UK Trial of Early Detection of Breast Cancer. Lancet 353(9168): 1909-1914.
66. van der Waal D, Broeders MJM, Verbeek ALM, Duffy SW, Moss SM (2015) Case-control studies on the effectiveness of breast cancer screening: Insights from the UK Age Trial. Epidemiology 26(4): 590-596.
67. Weedon-FekjIr H, Romundstad PR, Vatten LJ (2014) Modern mammography screening and breast cancer mortality: population study. BMJ 348: g3701.